among dietary polyphenols, it is relatively well absorbed and can cross the bloodbrain barrier (42), making it a particularly interesting molecule for potential neuroprotective therapy
So like probiotics, we have been using yogurt for centuries, right
[11] [12] Currently available GLP-1 receptor agonists in the United States include semaglutide (Ozempic, Wegovy, Rybelsus), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), exenatide (Byetta, Bydureon BCise), and tirzepatide (Mounjaro, Zepbound)though tirzepatide is technically a dual GLP-1/GIP receptor agonist
Real-world data show that GLP-1 use in people with T2D was associated with higher rates of #GERD and related complications compared with SGLT-2 inhibitors
Recent studies have also explored its potential in reducing pain and inflammation in the digestive tract, indicating its potential as a therapy for inflammatory bowel disease and irritable bowel syndrome